Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction

被引:87
|
作者
Wittenberg, Ruthie E. [1 ]
Wolfman, Shannon L. [1 ]
De Biasi, Mariella [1 ,2 ]
Dani, John A. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Dept Neurosci, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Dept Psychiat, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
LUNG-CANCER; SUSCEPTIBILITY LOCUS; ASSOCIATION; WITHDRAWAL; SMOKING; GENES; SYSTEM; DEPENDENCE; SUBUNITS; VARIANT;
D O I
10.1016/j.neuropharm.2020.108256
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Nicotine is a highly addictive drug found in tobacco that drives its continued use despite the harmful consequences. The initiation of nicotine abuse involves the mesolimbic dopamine system, which contributes to the rewarding sensory stimuli and associative learning processes in the beginning stages of addiction. Nicotine binds to neuronal nicotinic acetylcholine receptors (nAChRs), which come in a diverse collection of subtypes. The nAChRs that contain the alpha 4 and beta 2 subunits, often in combination with the alpha 6 subunit, are particularly important for nicotine's ability to increase midbrain dopamine neuron firing rates and phasic burst firing. Chronic nicotine exposure results in numerous neuroadaptations, including the upregulation of particular nAChR subtypes associated with long-term desensitization of the receptors. When nicotine is no longer present, for example during attempts to quit smoking, a withdrawal syndrome develops. The expression of physical withdrawal symptoms depends mainly on the alpha 2, alpha 3, alpha 5, and beta 4 nicotinic subunits in the epithalamic habenular complex and its target regions. Thus, nicotine affects diverse neural systems and an array of nAChR subtypes to mediate the overall addiction process.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Potentiation of the actions of acetylcholine, epibatidine, and nicotine by methyllycaconitine at fetal muscle-type nicotinic acetylcholine receptors
    Green, Benedict T.
    Welch, Kevin D.
    Cook, Daniel
    Gardner, Dale R.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 662 (1-3) : 15 - 21
  • [42] Nicotinic receptors: Modulation by nicotine
    Arneric, Stephen P.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S18 - S18
  • [43] Nicotinic Receptors in Addiction Pathways
    Leslie, Frances M.
    Mojica, Celina Y.
    Reynaga, Daisy D.
    MOLECULAR PHARMACOLOGY, 2013, 83 (04) : 753 - 758
  • [44] Nicotinic acetylcholine receptors and epilepsy
    Becchetti, Andrea
    Grandi, Laura Clara
    Cerina, Marta
    Amadeo, Alida
    PHARMACOLOGICAL RESEARCH, 2023, 189
  • [45] ''Neuronal'' nicotinic acetylcholine receptors
    Lukas, RJ
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S161 - S161
  • [46] Nicotinic acetylcholine receptors and cancer
    Dang, Ningning
    Meng, Xianguang
    Song, Haiyan
    BIOMEDICAL REPORTS, 2016, 4 (05) : 515 - 518
  • [47] Nicotinic acetylcholine receptors and imaging
    Gündisch, D
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (11) : 1143 - 1157
  • [48] Tying up Nicotine: New Selective Competitive Antagonist of the Neuronal Nicotinic Acetylcholine Receptors
    Petersen, Ida Nymann
    Crestey, Francois
    Jensen, Anders A.
    Indurthi, Dinesh C.
    Pedersen, Henrik
    Andreasen, Jesper T.
    Balle, Thomas
    Kristensen, Jesper L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (04): : 472 - 475
  • [49] The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine
    Palmatier, Matthew I.
    Liu, Xiu
    Caggiula, Anthony R.
    Donny, Eric C.
    Sved, Alan F.
    NEUROPSYCHOPHARMACOLOGY, 2007, 32 (05) : 1098 - 1108
  • [50] Understanding of nicotinic acetylcholine receptors
    Jie Wu
    Acta Pharmacologica Sinica, 2009, 30 : 653 - 655